Arius Research Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 31

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $180M

Arius Research General Information

Description

Developer of anticancer monoclonal antibodies therapeutics. The company offers a proprietary technology platform that identifies monoclonal antibodies targeting a variety of cancer indications and engages in the discovery and development of antibody therapeutics primarily focusing on breast, prostate, ovarian, colorectal, pancreatic and lung cancers, leukemia and melanoma.

Contact Information

Formerly Known As
Arius Rearch Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 55 York Street
  • 16th Floor
  • Toronto, Ontario M5J 1R7
  • Canada
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Acquirer
Norda Stelo
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 55 York Street
  • 16th Floor
  • Toronto, Ontario M5J 1R7
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arius Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 23-Sep-2008 $180M Completed Generating Revenue
4. PIPE 01-Mar-2006 Completed Generating Revenue
3. PIPE 19-Sep-2005 Completed Generating Revenue
2. PIPE 21-Oct-2004 $2.02M $5.2M Completed Generating Revenue
1. IPO 10-May-2000 $3.38M $3.17M Completed Generating Revenue
To view Arius Research’s complete valuation and funding history, request access »

Arius Research Patents

Arius Research Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20100158801-A1 Methods for the treatment of acute myeloid leukemia Inactive 23-Dec-2008
US-20100015045-A1 Cancerous disease modifying antibodies Inactive 17-Jul-2008
US-20090191119-A1 Cancerous disease modifying antibodies Inactive 28-Jan-2008
US-20090191120-A1 Cancerous disease modifying antibodies Inactive 28-Jan-2008
US-20090191197-A1 Cancerous disease modifying antibodies Inactive 28-Jan-2008 C07K16/30
To view Arius Research’s complete patent history, request access »

Arius Research Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arius Research Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
BVF Partners Hedge Fund Minority
Efficacy Capital Venture Capital Minority
National Research Council Canada Government Minority
OrbiMed Growth/Expansion Minority
Xmark Asset Management Venture Capital Minority
To view Arius Research’s complete investors history, request access »

Arius Research FAQs

  • When was Arius Research founded?

    Arius Research was founded in 1999.

  • Where is Arius Research headquartered?

    Arius Research is headquartered in Toronto, Canada.

  • What is the size of Arius Research?

    Arius Research has 31 total employees.

  • What industry is Arius Research in?

    Arius Research’s primary industry is Discovery Tools (Healthcare).

  • Is Arius Research a private or public company?

    Arius Research is a Private company.

  • What is the current valuation of Arius Research?

    The current valuation of Arius Research is .

  • What is Arius Research’s current revenue?

    The current revenue for Arius Research is .

  • How much funding has Arius Research raised over time?

    Arius Research has raised $26.4M.

  • Who are Arius Research’s investors?

    BVF Partners, Efficacy Capital, National Research Council Canada, OrbiMed, and Xmark Asset Management have invested in Arius Research.

  • When was Arius Research acquired?

    Arius Research was acquired on 23-Sep-2008.

  • Who acquired Arius Research?

    Arius Research was acquired by Norda Stelo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »